Clinical trials
Phase 3 Carcinoma, Hepatocellular trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
149 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 6 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 5 |
| 2012 | 1 |
| 2013 | 9 |
| 2014 | 6 |
| 2015 | 7 |
| 2016 | 9 |
| 2017 | 9 |
| 2018 | 11 |
| 2019 | 19 |
| 2020 | 6 |
| 2021 | 7 |
| 2022 | 12 |
| 2023 | 9 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 53 |
| Completed | 45 |
| Recruiting | 21 |
| Active, not recruiting | 11 |
| Not yet recruiting | 7 |
| Terminated | 7 |
| Withdrawn | 4 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 47 |
| Guangxi Medical University | 11 |
| AstraZeneca | 6 |
| Fudan University | 6 |
| Shanghai Zhongshan Hospital | 6 |
| Bayer | 4 |
| Bristol-Myers Squibb | 4 |
| Hoffmann-La Roche | 4 |
| Merck Sharp & Dohme LLC | 4 |
| Second Affiliated Hospital of Guangzhou Medical University | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 149 |
| Liver Neoplasms | 18 |
| Neoplasms | 6 |
| Recurrence | 6 |
| Carcinoma | 4 |
| Neoplasms, Glandular and Epithelial | 3 |
| Adenocarcinoma | 2 |
| Digestive System Diseases | 2 |
| Digestive System Neoplasms | 2 |
| Liver Diseases | 2 |
Trials
Showing 1 to 25 of 149. Each trial links to its page on Pharma Observatory.
49 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.